Navigation Links
Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum
Date:4/10/2008

SANTA CLARA, Calif., April 10 /PRNewswire/ -- Dedicating this year's Venture Forum to the life sciences industry, Larta Institute and Burrill & Company have announced a partnership in developing and producing the 2008 Life Sciences Venture Forum, which will showcase the most promising and innovative seed and early-stage life sciences companies from the U.S. and around the globe. The 2008 Life Sciences Venture Forum will take place on May 30, 2008, at the Santa Clara Convention Center and will provide venture capitalists, angel investors and industry representatives the opportunity to get a first look at companies that are not seen on the regular conference circuit and cannot be accessed via traditional pipelines.

"This partnership unites the best of the best," said Rohit Shukla, CEO of Larta Institute. "It extends the reach, brand and credibility of Burrill & Company to the world of early-stage innovations and Larta Institute's own focus and access to that pool of talent," he added. "With this partnership, the Venture Forum grows several notches."

G. Steven Burrill, CEO of Burrill & Company, said, "Different areas of discovery are converging in the life sciences. There is no more exciting a time for emerging innovations to fill large holes in the realization of these trends." He added that "the 2008 Life Sciences Venture Forum promises to be an important platform for demonstration and feedback of these innovations, and we are excited to be a part of it."

Now 14 years strong, the Venture Forum is the largest and longest-running showcase of early stage innovation and entrepreneurship. It is the must-attend event for those seeking access to untapped early-stage deal flow from around the world.

Larta Institute's Commercialization Assistance Practice is rooted in a set of year-round programs that uncover, coach and train innovators funded by institutions such as the National Institutes of Health, the US Department of Agriculture and a n
'/>"/>

SOURCE Larta Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Loma Linda University Partners With Larta Institute for Technology Marketing Program
2. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
3. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
4. Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research
5. Piedmont Heart Institute Welcomes Cardiology of Georgia
6. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
7. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
8. Aida Acquires High-Level Research Institute in China
9. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
10. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
11. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Sterlitech is proud to debut its multi-line, fully ... AMTA Membrane Technology Conference in Orlando. This new ... engineering and customer feedback, which has resulted in a ... across an array of disciplines. It is designed ... of researchers and engineers alike and is ideal for ...
(Date:2/28/2015)... Increasing its efforts to resolve the GMO Controversy , ... The GMO TRUTH podcast on both ITunes and at The ... mission to discover the truth and change the world. ... truth about the GMOs in our food supply,” adds a ... an expansion of the documentary/investigative film-making methodology in place at ...
(Date:2/27/2015)... 27, 2015 A paper published today, ... portfolio " in Science Translational Medicine, ... to reduce the risk associated with investing in ... new levels of funding for developing so-called "orphan" ... unique collaboration between scientists at the National Center ...
(Date:2/27/2015)... Feb. 27, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) ... trial of BNC105 in patients with metastatic renal cancer ... Orlando, Florida . The data will be presented ... of Hope Comprehensive Cancer Center in California ... The new data identifies Ferritin and IL-8 as two ...
Breaking Biology Technology:Sterlitech Displays Complete CF042 Membrane Test System 2The Walk a Mile Project Launches “GMO Truth” Podcast 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5
... and WEYBRIDGE, England, Dec. 6, 2010 ViroPharma ... the global leader in developing long-term strategic solutions ... companies have partnered to facilitate access to certain ...  ViroPharma,s NPP, developed and managed by Idis, will ...
... Clarient, Inc. ("Clarient") (Nasdaq: CLRT ) announced today ... Crane Merger Sub, Inc. ("Purchaser"), an indirect wholly-owned subsidiary of ... to acquire all of the outstanding shares of capital stock ... Offer from midnight, New York City time, at the end ...
... Institute (BRI), the research arm of Baylor Health Care ... with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly ... at the Baylor Institute for Immunology Research (BIIR), a ... BIIR,s leading position in human immunology with particular focus ...
Cached Biology Technology:ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program 2ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program 3Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation 2Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation 3Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation 4Roche, Baylor Research Institute Partner in Human Immunology Research 2
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... , January 28, 2015 ... Analysis, Size And Segment Forecasts To 2020 has Been ... IR camera market is expected to reach USD 5.10 ... Grand View Research, Inc. IR cameras help identify the ... are expected to witness surging demand in medical imaging ...
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition ... report to their offering. , The primary ... is who she/he is claiming to be, and for this ... physical characteristics, such as fingerprint, hand or palm print, iris, ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... January 28, 2014 Scientists at Harvard University ... of the natural nanoscale photonic device that enables a ... inspire improved protective camouflage for soldiers on the battlefield. ... sea," can rapidly alter both the color and pattern ...
... A University of Colorado Cancer Center study published today ... and Physics shows that patients taking crizotinib for ... use up to three courses of targeted radiation therapy ... of resistant disease allows patients to continue treating the ...
... advanceselectronic devices, the iPhone, medical implants, disease detection ... of revolutionary interfaces. The study of creating and ... engineeringis one of the most exciting research frontiers. ... of Engineering will welcome leading engineers, physicists, chemists, ...
Cached Biology News:'Chameleon of the sea' reveals its secrets 2'Chameleon of the sea' reveals its secrets 3'Weeding the garden' lets ALK+ lung cancer patients continue crizotinib 2'Weeding the garden' lets ALK+ lung cancer patients continue crizotinib 3Interfacing with the future 2
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure su...
... Detection of the yolk protein Vtg in ... simple and sensitive biomarker for endocrine disrupting chemicals ... Vtg has become an accepted screening test for ... Vtg (rainbow trout) EIA kit is a double-antibody ...
Biology Products: